XXL Heading (h1)

RNAscope™ technology enables faster and more rigorous target and biomarker development: it is a robust and ultra-sensitive RNA in situ hybridization (RNA ISH) method providing single-cell and single-molecule RNA detection in the context of complex tissue microenvironments. Advanced Cell Diagnostics’ Assay Services group is the only CRO specialized in providing RNAscope, BaseScope™ and miRNAscope in situ hybridization (ISH) services for tissue-based and cell specific analysis of targets and biomarkers in as little as 4 weeks.

Please join us to hear how our services are contributing to and advancing the research and therapeutic development at hundreds of academic and clinical institutions in the field of immuno-oncology, neuroscience, ophthalmology, metabolic disorders, respiratory disease, and toxicological pathology.

LEARNING OBJECTIVES

• Visualize the cellular heterogeneity of complex organs with the multiplexing and spatial capabilities of the RNAscope™ Multiplex Fluorescent assay

• Spatially map scRNA-seq gene profiles at the single cell level in the tissue context as well as confirm scRNA-seq results from publicly available datasets in the tissue context

• Quantifiable, single-molecule detection of biomarker RNA in fixed biopsies

• Detect splice variants, point mutations and short target sequences with BaseScope ISH assays

• Spatial mapping of stem cell markers in various tissue types such as organoids, frozen and FFPE tissues

• Localize newly identified cell subtypes and cell markers using our ISH/IHC co-detection technology

• Specific detection of engineered CAR-T and TCR-T cell therapies in clinical trial patient biopsies

• Leverage RNAscope Quality-controlled tissue bank including solid tumors, normal human tissues, and TMAs to accelerate your research
  

		Victoria Huang, Ph.D. Senior Research Associate Advanced Cell Diagnostics, a Bio-Techne Brand

		Anisha Madhav, Ph.D. Technical Support Specialist Advanced Cell Diagnostics, a Bio-Techne Brand